MAXALT MRK267 (Maxalt 10 mg)
Generic Name: rizatriptan
Pill imprint MAXALT MRK267 has been identified as Maxalt 10 mg.
Maxalt is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Maxalt 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- MAXALT MRK267
- 10 mg
- 12.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Merck & Company Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
ferric oxide red
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|52959-0786||H.J. Harkins Company, Inc (repackager)|
|68071-0262||Nucare Pharmaceuticals Inc (repackager)|
|54868-4251||Physicians Total Care Inc (repackager)|
|35356-0252||Lake Erie Medical and Surgical Supply (repackager)|
|16590-0461||Stat RX USA LLC (repackager)|
|21695-0956||Rebel Distributors Corp (repackager)|
More about Maxalt (rizatriptan)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 89 Reviews – Add your own review/rating
- Generic Availability
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.